$NTII Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEUROBIOLOGICAL TECHNOLOGIES INC /CA/.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NEUROBIOLOGICAL TECHNOLOGIES INC /CA/. Get notifications about new insider transactions in NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 09 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 12,796 | 960 | 1,994,798 | 2 M to 2 M (-0.64 %) |
Jun 09 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 7,737 | 580 | 2,618,424 | 2.6 M to 2.6 M (-0.29 %) |
May 21 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 60,060 | 4,505 | 2,007,594 | 2.1 M to 2 M (-2.90 %) |
May 21 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 39,940 | 2,996 | 2,626,161 | 2.7 M to 2.6 M (-1.50 %) |
May 21 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 18,018 | 1,351 | 2,067,654 | 2.1 M to 2.1 M (-0.86 %) |
May 21 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 11,982 | 899 | 2,666,101 | 2.7 M to 2.7 M (-0.45 %) |
May 21 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 26,547 | 1,991 | 2,085,672 | 2.1 M to 2.1 M (-1.26 %) |
May 21 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 17,653 | 1,324 | 2,678,083 | 2.7 M to 2.7 M (-0.65 %) |
May 13 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 153,153 | 11,486 | 2,112,219 | 2.3 M to 2.1 M (-6.76 %) |
May 13 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 101,847 | 7,639 | 2,695,736 | 2.8 M to 2.7 M (-3.64 %) |
May 04 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 6,006 | 450 | 2,265,372 | 2.3 M to 2.3 M (-0.26 %) |
May 04 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 3,994 | 300 | 2,797,583 | 2.8 M to 2.8 M (-0.14 %) |
May 04 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 33,634 | 2,523 | 2,271,378 | 2.3 M to 2.3 M (-1.46 %) |
May 04 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 22,366 | 1,677 | 2,801,577 | 2.8 M to 2.8 M (-0.79 %) |
Apr 29 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 562 | 42 | 2,305,012 | 2.3 M to 2.3 M (-0.02 %) |
Apr 29 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 438 | 33 | 2,823,943 | 2.8 M to 2.8 M (-0.02 %) |
Apr 29 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 10,120 | 759 | 2,305,574 | 2.3 M to 2.3 M (-0.44 %) |
Apr 29 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 7,880 | 591 | 2,824,381 | 2.8 M to 2.8 M (-0.28 %) |
Apr 26 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 1,045 | 78 | 2,315,694 | 2.3 M to 2.3 M (-0.05 %) |
Apr 26 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 813 | 61 | 2,832,261 | 2.8 M to 2.8 M (-0.03 %) |
Apr 26 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 11,919 | 894 | 2,316,739 | 2.3 M to 2.3 M (-0.51 %) |
Apr 26 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 9,281 | 696 | 2,833,074 | 2.8 M to 2.8 M (-0.33 %) |
Apr 26 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 4,441 | 347 | 2,328,658 | 2.3 M to 2.3 M (-0.19 %) |
Apr 26 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 3,459 | 270 | 2,842,355 | 2.8 M to 2.8 M (-0.12 %) |
Apr 22 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 7,847 | 589 | 2,333,099 | 2.3 M to 2.3 M (-0.34 %) |
Apr 22 2010 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Sell | P | 0.08 | 6,111 | 458 | 2,845,814 | 2.9 M to 2.8 M (-0.21 %) |
Nov 09 2009 | NTII | NEUROBIOLOGICAL TE ... | COHEN ABRAHAM E | Director | Option Exercise | M | 0.65 | 15,000 | 9,750 | 0 | |
Nov 09 2009 | NTII | NEUROBIOLOGICAL TE ... | COHEN ABRAHAM E | Director | Buy | M | 0.65 | 15,000 | 9,750 | 133,707 | 118.7 K to 133.7 K (+12.64 %) |
Dec 30 2009 | NTII | NEUROBIOLOGICAL TE ... | STUPPIN JOHN B | Director | Sell | S | 0.12 | 5,608 | 673 | 183,876 | 189.5 K to 183.9 K (-2.96 %) |
Oct 29 2009 | NTII | NEUROBIOLOGICAL TE ... | ELIOT THEODORE | Director | Option Exercise | M | 0.65 | 15,000 | 9,750 | 0 | |
Oct 29 2009 | NTII | NEUROBIOLOGICAL TE ... | ELIOT THEODORE | Director | Buy | M | 0.65 | 15,000 | 9,750 | 17,617 | 2.6 K to 17.6 K (+573.18 %) |
Oct 29 2009 | NTII | NEUROBIOLOGICAL TE ... | Fletcher William A | Acting Chief Execut ... | Option Exercise | M | 0.65 | 15,000 | 9,750 | 0 | |
Oct 29 2009 | NTII | NEUROBIOLOGICAL TE ... | Fletcher William A | Acting Chief Execut ... | Buy | M | 0.65 | 15,000 | 9,750 | 83,600 | 68.6 K to 83.6 K (+21.87 %) |
Oct 29 2009 | NTII | NEUROBIOLOGICAL TE ... | SOFAER ABRAHAM D | Director | Option Exercise | M | 0.65 | 15,000 | 9,750 | 0 | |
Oct 29 2009 | NTII | NEUROBIOLOGICAL TE ... | SOFAER ABRAHAM D | Director | Buy | M | 0.65 | 15,000 | 9,750 | 125,931 | 110.9 K to 125.9 K (+13.52 %) |
Oct 29 2009 | NTII | NEUROBIOLOGICAL TE ... | KASPER F VAN | Director | Option Exercise | M | 0.65 | 15,000 | 9,750 | 0 | |
Oct 29 2009 | NTII | NEUROBIOLOGICAL TE ... | KASPER F VAN | Director | Buy | M | 0.65 | 15,000 | 9,750 | 58,600 | 43.6 K to 58.6 K (+34.40 %) |
Oct 29 2009 | NTII | NEUROBIOLOGICAL TE ... | STUPPIN JOHN B | Director | Option Exercise | M | 0.65 | 15,000 | 9,750 | 0 | |
Oct 29 2009 | NTII | NEUROBIOLOGICAL TE ... | STUPPIN JOHN B | Director | Buy | M | 0.65 | 15,000 | 9,750 | 189,484 | 174.5 K to 189.5 K (+8.60 %) |
Oct 26 2009 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Buy | P | 0.90 | 81,561 | 73,397 | 2,340,946 | 2.3 M to 2.3 M (+3.61 %) |
Oct 26 2009 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Buy | P | 0.90 | 99,365 | 89,419 | 2,851,925 | 2.8 M to 2.9 M (+3.61 %) |
Oct 26 2009 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Buy | P | 0.91 | 135,442 | 123,022 | 2,259,385 | 2.1 M to 2.3 M (+6.38 %) |
Oct 26 2009 | NTII | NEUROBIOLOGICAL TE ... | Firefly Value Partners, LP | 10% Owner | Buy | P | 0.91 | 165,007 | 149,876 | 2,752,560 | 2.6 M to 2.8 M (+6.38 %) |
Oct 23 2009 | NTII | NEUROBIOLOGICAL TE ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 0.91 | 2,692,493 | 2,450,169 | 331,998 | 3 M to 332 K (-89.02 %) |
Oct 23 2009 | NTII | NEUROBIOLOGICAL TE ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 0.91 | 777,408 | 707,441 | 3,024,491 | 3.8 M to 3 M (-20.45 %) |
Oct 23 2009 | NTII | NEUROBIOLOGICAL TE ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 0.91 | 1,136,494 | 1,034,210 | 3,801,899 | 4.9 M to 3.8 M (-23.01 %) |
Feb 12 2009 | NTII | NEUROBIOLOGICAL TE ... | FREIMAN PAUL E | Sell | S | 0.21 | 66 | 14 | 14,920 | 15 K to 14.9 K (-0.44 %) | |
Feb 12 2009 | NTII | NEUROBIOLOGICAL TE ... | FREIMAN PAUL E | Sell | S | 0.21 | 400 | 84 | 14,986 | 15.4 K to 15 K (-2.60 %) | |
Feb 12 2009 | NTII | NEUROBIOLOGICAL TE ... | FREIMAN PAUL E | Sell | S | 0.58 | 30 | 17 | 15,386 | 15.4 K to 15.4 K (-0.19 %) | |
Feb 12 2009 | NTII | NEUROBIOLOGICAL TE ... | FREIMAN PAUL E | Sell | S | 0.56 | 970 | 543 | 15,416 | 16.4 K to 15.4 K (-5.92 %) | |
Feb 12 2009 | NTII | NEUROBIOLOGICAL TE ... | FREIMAN PAUL E | Sell | S | 0.61 | 1,000 | 610 | 16,386 | 17.4 K to 16.4 K (-5.75 %) | |
Nov 18 2008 | NTII | NEUROBIOLOGICAL TE ... | J P MORGAN CHASE & CO | 10% Owner | Sell | S | 0.48 | 2,962,340 | 1,410,666 | 0 | 3 M to 0 (-100.00 %) |
Nov 17 2008 | NTII | NEUROBIOLOGICAL TE ... | COHEN ABRAHAM E | Director | Option Exercise | A | 0.65 | 15,000 | 9,750 | 15,000 | |
Nov 17 2008 | NTII | NEUROBIOLOGICAL TE ... | KASPER F VAN | Director | Option Exercise | A | 0.65 | 15,000 | 9,750 | 15,000 | |
Nov 17 2008 | NTII | NEUROBIOLOGICAL TE ... | ELIOT THEODORE | Director | Option Exercise | A | 0.65 | 15,000 | 9,750 | 15,000 | |
Nov 17 2008 | NTII | NEUROBIOLOGICAL TE ... | Fletcher William A | Director | Option Exercise | A | 0.65 | 15,000 | 9,750 | 15,000 | |
Nov 17 2008 | NTII | NEUROBIOLOGICAL TE ... | STUPPIN JOHN B | Director | Option Exercise | A | 0.65 | 15,000 | 9,750 | 15,000 | |
Nov 17 2008 | NTII | NEUROBIOLOGICAL TE ... | SOFAER ABRAHAM D | Director | Option Exercise | A | 0.65 | 15,000 | 9,750 | 15,000 | |
Nov 14 2008 | NTII | NEUROBIOLOGICAL TE ... | Wasiewski Warren W | Vice President, CMO | Buy | P | 0.66 | 10,000 | 6,600 | 10,000 | 0 to 10 K |
Nov 04 2008 | NTII | NEUROBIOLOGICAL TE ... | DONDERO JAMES D | 10% Owner | Sell | D | 0.49 | 213,675 | 104,701 | 4,737,479 | 5 M to 4.7 M (-4.32 %) |
Nov 13 2008 | NTII | NEUROBIOLOGICAL TE ... | Fletcher William A | Director | Buy | P | 0.66 | 10,000 | 6,600 | 68,600 | 58.6 K to 68.6 K (+17.06 %) |
Oct 30 2008 | NTII | NEUROBIOLOGICAL TE ... | Fletcher William A | Director | Buy | P | 0.65 | 5,000 | 3,250 | 58,600 | 53.6 K to 58.6 K (+9.33 %) |
Oct 30 2008 | NTII | NEUROBIOLOGICAL TE ... | Fletcher William A | Director | Buy | P | 0.70 | 10,000 | 7,000 | 53,600 | 43.6 K to 53.6 K (+22.94 %) |
Oct 20 2008 | NTII | NEUROBIOLOGICAL TE ... | J P MORGAN CHASE & CO | 10% Owner | Sell | S | 0.44 | 158,300 | 69,652 | 2,962,340 | 3.1 M to 3 M (-5.07 %) |
Oct 20 2008 | NTII | NEUROBIOLOGICAL TE ... | J P MORGAN CHASE & CO | 10% Owner | Sell | S | 0.50 | 211,100 | 105,550 | 3,120,640 | 3.3 M to 3.1 M (-6.34 %) |
Oct 20 2008 | NTII | NEUROBIOLOGICAL TE ... | J P MORGAN CHASE & CO | 10% Owner | Sell | S | 0.47 | 3,304 | 1,553 | 3,331,740 | 3.3 M to 3.3 M (-0.10 %) |
Oct 20 2008 | NTII | NEUROBIOLOGICAL TE ... | J P MORGAN CHASE & CO | 10% Owner | Sell | S | 0.55 | 17,900 | 9,845 | 3,335,044 | 3.4 M to 3.3 M (-0.53 %) |
Oct 20 2008 | NTII | NEUROBIOLOGICAL TE ... | J P MORGAN CHASE & CO | 10% Owner | Sell | S | 0.53 | 41,550 | 22,022 | 3,352,944 | 3.4 M to 3.4 M (-1.22 %) |
Oct 20 2008 | NTII | NEUROBIOLOGICAL TE ... | J P MORGAN CHASE & CO | 10% Owner | Sell | S | 0.66 | 24,320 | 16,051 | 3,394,494 | 3.4 M to 3.4 M (-0.71 %) |
Oct 20 2008 | NTII | NEUROBIOLOGICAL TE ... | J P MORGAN CHASE & CO | 10% Owner | Sell | S | 0.65 | 2,700 | 1,755 | 3,418,814 | 3.4 M to 3.4 M (-0.08 %) |
Oct 20 2008 | NTII | NEUROBIOLOGICAL TE ... | J P MORGAN CHASE & CO | 10% Owner | Sell | S | 0.63 | 29,150 | 18,365 | 3,421,514 | 3.5 M to 3.4 M (-0.84 %) |
Oct 20 2008 | NTII | NEUROBIOLOGICAL TE ... | J P MORGAN CHASE & CO | 10% Owner | Sell | S | 0.72 | 71,100 | 51,192 | 3,450,664 | 3.5 M to 3.5 M (-2.02 %) |
Oct 20 2008 | NTII | NEUROBIOLOGICAL TE ... | J P MORGAN CHASE & CO | 10% Owner | Sell | S | 0.78 | 163,567 | 127,582 | 3,521,764 | 3.7 M to 3.5 M (-4.44 %) |
Oct 20 2008 | NTII | NEUROBIOLOGICAL TE ... | J P MORGAN CHASE & CO | 10% Owner | Sell | S | 0.89 | 38,423 | 34,196 | 3,685,331 | 3.7 M to 3.7 M (-1.03 %) |
Oct 23 2008 | NTII | NEUROBIOLOGICAL TE ... | LOAR MATTHEW M | VP and Chief Financ ... | Buy | P | 0.75 | 25,000 | 18,750 | 25,000 | 0 to 25 K |
Oct 16 2008 | NTII | NEUROBIOLOGICAL TE ... | STUPPIN JOHN B | Director | Buy | P | 0.87 | 1,000 | 870 | 174,484 | 173.5 K to 174.5 K (+0.58 %) |
Oct 16 2008 | NTII | NEUROBIOLOGICAL TE ... | STUPPIN JOHN B | Director | Buy | P | 0.85 | 9,000 | 7,650 | 173,484 | 164.5 K to 173.5 K (+5.47 %) |
Jun 03 2008 | NTII | NEUROBIOLOGICAL TE ... | FREIMAN PAUL E | President and CEO | Option Exercise | A | 3.00 | 300,000 | 900,000 | 300,000 | |
Jun 03 2008 | NTII | NEUROBIOLOGICAL TE ... | Levy David E | VP of Clinical Deve ... | Option Exercise | A | 2.08 | 125,000 | 260,000 | 125,000 | |
Jun 03 2008 | NTII | NEUROBIOLOGICAL TE ... | SOFAER ABRAHAM D | Director | Option Exercise | A | 3.00 | 40,000 | 120,000 | 40,000 | |
Jun 03 2008 | NTII | NEUROBIOLOGICAL TE ... | KASPER F VAN | Director | Option Exercise | A | 3.00 | 52,000 | 156,000 | 52,000 | |
Jun 03 2008 | NTII | NEUROBIOLOGICAL TE ... | COHEN ABRAHAM E | Director | Option Exercise | A | 3.00 | 60,000 | 180,000 | 60,000 | |
Jun 03 2008 | NTII | NEUROBIOLOGICAL TE ... | ELIOT THEODORE | Director | Option Exercise | A | 3.00 | 40,000 | 120,000 | 40,000 | |
Jun 03 2008 | NTII | NEUROBIOLOGICAL TE ... | Fletcher William A | Director | Option Exercise | A | 3.00 | 40,000 | 120,000 | 40,000 | |
Jun 03 2008 | NTII | NEUROBIOLOGICAL TE ... | STUPPIN JOHN B | Director | Option Exercise | A | 3.00 | 40,000 | 120,000 | 40,000 | |
Jun 03 2008 | NTII | NEUROBIOLOGICAL TE ... | Wasiewski Warren W | Chief Medical Offic ... | Option Exercise | A | 2.08 | 250,000 | 520,000 | 250,000 | |
Feb 14 2008 | NTII | NEUROBIOLOGICAL TE ... | CALLAWAY ENOCH | Director | Option Exercise | A | 2.55 | 10,000 | 25,500 | 10,000 | |
Jan 03 2008 | NTII | NEUROBIOLOGICAL TE ... | HIGHLAND CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 2.88 | 50,000 | 144,000 | 4,951,154 | 4.9 M to 5 M (+1.02 %) |
Jan 02 2008 | NTII | NEUROBIOLOGICAL TE ... | KASPER F VAN | Director | Sell | S | 2.91 | 100 | 291 | 43,601 | 43.7 K to 43.6 K (-0.23 %) |
Jan 02 2008 | NTII | NEUROBIOLOGICAL TE ... | KASPER F VAN | Director | Sell | S | 2.90 | 14,119 | 40,945 | 43,701 | 57.8 K to 43.7 K (-24.42 %) |
Jan 02 2008 | NTII | NEUROBIOLOGICAL TE ... | KASPER F VAN | Director | Sell | S | 2.92 | 5,780 | 16,878 | 57,820 | 63.6 K to 57.8 K (-9.09 %) |
Dec 28 2007 | NTII | NEUROBIOLOGICAL TE ... | HIGHLAND CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 2.94 | 16,400 | 48,186 | 4,901,154 | 4.9 M to 4.9 M (+0.34 %) |
Dec 28 2007 | NTII | NEUROBIOLOGICAL TE ... | HIGHLAND CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 2.96 | 24,800 | 73,443 | 4,884,754 | 4.9 M to 4.9 M (+0.51 %) |
Dec 28 2007 | NTII | NEUROBIOLOGICAL TE ... | HIGHLAND CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 3.00 | 7,200 | 21,599 | 4,859,954 | 4.9 M to 4.9 M (+0.15 %) |
Dec 21 2007 | NTII | NEUROBIOLOGICAL TE ... | HIGHLAND CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 3.00 | 6,100 | 18,300 | 4,852,754 | 4.8 M to 4.9 M (+0.13 %) |
Dec 21 2007 | NTII | NEUROBIOLOGICAL TE ... | HIGHLAND CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 3.00 | 26,700 | 80,100 | 4,846,654 | 4.8 M to 4.8 M (+0.55 %) |
Dec 05 2007 | NTII | NEUROBIOLOGICAL TE ... | STUPPIN JOHN B | Director | Buy | P | 3.26 | 7,000 | 22,820 | 164,484 | 157.5 K to 164.5 K (+4.44 %) |
Dec 05 2007 | NTII | NEUROBIOLOGICAL TE ... | STUPPIN JOHN B | Director | Buy | P | 3.32 | 7,800 | 25,896 | 157,484 | 149.7 K to 157.5 K (+5.21 %) |
Dec 05 2007 | NTII | NEUROBIOLOGICAL TE ... | STUPPIN JOHN B | Director | Buy | P | 3.31 | 200 | 662 | 149,684 | 149.5 K to 149.7 K (+0.13 %) |
Dec 05 2007 | NTII | NEUROBIOLOGICAL TE ... | STUPPIN JOHN B | Director | Buy | P | 3.30 | 2,000 | 6,600 | 149,484 | 147.5 K to 149.5 K (+1.36 %) |
Dec 18 2007 | NTII | NEUROBIOLOGICAL TE ... | HIGHLAND CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 3.00 | 50,000 | 150,000 | 4,819,954 | 4.8 M to 4.8 M (+1.05 %) |
Dec 18 2007 | NTII | NEUROBIOLOGICAL TE ... | HIGHLAND CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 3.00 | 25,000 | 75,000 | 4,769,954 | 4.7 M to 4.8 M (+0.53 %) |
Dec 18 2007 | NTII | NEUROBIOLOGICAL TE ... | HIGHLAND CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 2.99 | 50,000 | 149,500 | 4,744,954 | 4.7 M to 4.7 M (+1.06 %) |
Dec 18 2007 | NTII | NEUROBIOLOGICAL TE ... | HIGHLAND CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 3.00 | 25,000 | 75,000 | 4,694,954 | 4.7 M to 4.7 M (+0.54 %) |
Dec 18 2007 | NTII | NEUROBIOLOGICAL TE ... | HIGHLAND CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 3.00 | 50,000 | 150,000 | 4,669,954 | 4.6 M to 4.7 M (+1.08 %) |
Dec 05 2007 | NTII | NEUROBIOLOGICAL TE ... | FREIMAN PAUL E | President and CEO | Buy | P | 3.30 | 3,000 | 9,900 | 17,386 | 14.4 K to 17.4 K (+20.85 %) |
Dec 11 2007 | NTII | NEUROBIOLOGICAL TE ... | HIGHLAND CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 3.00 | 50,000 | 150,000 | 4,619,954 | 4.6 M to 4.6 M (+1.09 %) |
Dec 11 2007 | NTII | NEUROBIOLOGICAL TE ... | HIGHLAND CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 2.98 | 101,300 | 301,651 | 4,569,954 | 4.5 M to 4.6 M (+2.27 %) |
Dec 11 2007 | NTII | NEUROBIOLOGICAL TE ... | HIGHLAND CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 3.00 | 52,000 | 155,901 | 4,468,654 | 4.4 M to 4.5 M (+1.18 %) |
Nov 26 2007 | NTII | NEUROBIOLOGICAL TE ... | HIGHLAND CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 2.58 | 20,500 | 52,890 | 3,964,351 | 3.9 M to 4 M (+0.52 %) |
Nov 26 2007 | NTII | NEUROBIOLOGICAL TE ... | HIGHLAND CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 2.40 | 188,988 | 453,571 | 3,943,851 | 3.8 M to 3.9 M (+5.03 %) |
Nov 20 2007 | NTII | NEUROBIOLOGICAL TE ... | STUPPIN JOHN B | Director | Option Exercise | A | 2.54 | 1,428 | 3,627 | 1,428 | |
Nov 29 2007 | NTII | NEUROBIOLOGICAL TE ... | HIGHLAND CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 2.71 | 336,000 | 910,560 | 4,416,654 | 4.1 M to 4.4 M (+8.23 %) |
Nov 29 2007 | NTII | NEUROBIOLOGICAL TE ... | HIGHLAND CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 2.70 | 116,303 | 314,018 | 4,080,654 | 4 M to 4.1 M (+2.93 %) |
Nov 20 2007 | NTII | NEUROBIOLOGICAL TE ... | ELIOT THEODORE | Director | Option Exercise | A | 2.54 | 1,428 | 3,627 | 1,428 | |
Nov 20 2007 | NTII | NEUROBIOLOGICAL TE ... | Fletcher William A | Director | Option Exercise | A | 2.54 | 1,428 | 3,627 | 1,428 | |
Nov 20 2007 | NTII | NEUROBIOLOGICAL TE ... | COHEN ABRAHAM E | Director | Option Exercise | A | 2.54 | 1,428 | 3,627 | 1,428 | |
Nov 20 2007 | NTII | NEUROBIOLOGICAL TE ... | CAPE RONALD | Director | Option Exercise | A | 2.54 | 1,428 | 3,627 | 1,428 | |
Nov 20 2007 | NTII | NEUROBIOLOGICAL TE ... | SOFAER ABRAHAM D | Director | Option Exercise | A | 2.54 | 1,428 | 3,627 | 1,428 | |
Nov 20 2007 | NTII | NEUROBIOLOGICAL TE ... | CALLAWAY ENOCH | Director | Option Exercise | A | 2.54 | 1,428 | 3,627 | 1,428 | |
Nov 19 2007 | NTII | NEUROBIOLOGICAL TE ... | HIGHLAND CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 2.49 | 23,200 | 57,875 | 3,754,863 | 3.7 M to 3.8 M (+0.62 %) |
Nov 19 2007 | NTII | NEUROBIOLOGICAL TE ... | HIGHLAND CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 2.46 | 29,700 | 73,166 | 3,731,663 | 3.7 M to 3.7 M (+0.80 %) |
Nov 20 2007 | NTII | NEUROBIOLOGICAL TE ... | KASPER F VAN | Director | Option Exercise | A | 2.54 | 1,428 | 3,627 | 1,428 | |
Nov 13 2007 | NTII | NEUROBIOLOGICAL TE ... | Levy David E | VP of Clinical Deve ... | Buy | P | 2.63 | 10,000 | 26,300 | 13,115 | 3.1 K to 13.1 K (+321.03 %) |
Nov 15 2007 | NTII | NEUROBIOLOGICAL TE ... | HIGHLAND CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 2.40 | 8,600 | 20,640 | 3,701,963 | 3.7 M to 3.7 M (+0.23 %) |
Nov 15 2007 | NTII | NEUROBIOLOGICAL TE ... | HIGHLAND CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 2.39 | 57,000 | 136,127 | 3,693,363 | 3.6 M to 3.7 M (+1.57 %) |
Nov 06 2007 | NTII | NEUROBIOLOGICAL TE ... | COHEN ABRAHAM E | Director | Buy | P | 2.75 | 43,600 | 119,900 | 118,707 | 75.1 K to 118.7 K (+58.05 %) |
Nov 06 2007 | NTII | NEUROBIOLOGICAL TE ... | SOFAER ABRAHAM D | Director | Buy | P | 2.75 | 43,600 | 119,900 | 110,931 | 67.3 K to 110.9 K (+64.75 %) |
Nov 06 2007 | NTII | NEUROBIOLOGICAL TE ... | KASPER F VAN | Director | Sell | P | 2.75 | 43,600 | 119,900 | 63,600 | 107.2 K to 63.6 K (-40.67 %) |
Nov 06 2007 | NTII | NEUROBIOLOGICAL TE ... | STUPPIN JOHN B | Director | Buy | P | 2.75 | 43,600 | 119,900 | 147,484 | 103.9 K to 147.5 K (+41.97 %) |
Nov 01 2007 | NTII | NEUROBIOLOGICAL TE ... | CARLSON CRAIG W | VP and Chief Financ ... | Buy | P | 2.62 | 1,000 | 2,620 | 1,000 | 0 to 1,000 |
Nov 06 2007 | NTII | NEUROBIOLOGICAL TE ... | Fletcher William A | Director | Buy | P | 2.75 | 43,600 | 119,900 | 43,600 | 0 to 43.6 K |
Mar 14 2007 | NTII | NEUROBIOLOGICAL TE ... | SOFAER ABRAHAM D | Director | Option Exercise | M | 2.00 | 50,004 | 100,008 | 0 | |
Mar 14 2007 | NTII | NEUROBIOLOGICAL TE ... | SOFAER ABRAHAM D | Director | Option Exercise | M | 2.00 | 25,000 | 50,000 | 0 | |
Mar 14 2007 | NTII | NEUROBIOLOGICAL TE ... | SOFAER ABRAHAM D | Director | Payment of Exercise | F | 2.61 | 38,317 | 100,007 | 471,312 | 509.6 K to 471.3 K (-7.52 %) |
Mar 14 2007 | NTII | NEUROBIOLOGICAL TE ... | SOFAER ABRAHAM D | Director | Buy | M | 2.00 | 50,004 | 100,008 | 509,629 | 459.6 K to 509.6 K (+10.88 %) |
Mar 14 2007 | NTII | NEUROBIOLOGICAL TE ... | SOFAER ABRAHAM D | Director | Payment of Exercise | F | 2.61 | 19,157 | 50,000 | 459,625 | 478.8 K to 459.6 K (-4.00 %) |
Mar 14 2007 | NTII | NEUROBIOLOGICAL TE ... | SOFAER ABRAHAM D | Director | Buy | M | 2.00 | 25,000 | 50,000 | 478,782 | 453.8 K to 478.8 K (+5.51 %) |
Feb 23 2007 | NTII | NEUROBIOLOGICAL TE ... | FREIMAN PAUL E | President and CEO | Option Exercise | M | 1.75 | 109,563 | 191,735 | 0 | |
Feb 23 2007 | NTII | NEUROBIOLOGICAL TE ... | FREIMAN PAUL E | President and CEO | Option Exercise | M | 1.75 | 10,437 | 18,265 | 109,563 | |
Feb 23 2007 | NTII | NEUROBIOLOGICAL TE ... | FREIMAN PAUL E | President and CEO | Option Exercise | M | 2.00 | 25,000 | 50,000 | 0 | |
Feb 23 2007 | NTII | NEUROBIOLOGICAL TE ... | FREIMAN PAUL E | President and CEO | Sell | S | 2.61 | 64,563 | 168,535 | 100,700 | 165.3 K to 100.7 K (-39.07 %) |
Feb 23 2007 | NTII | NEUROBIOLOGICAL TE ... | FREIMAN PAUL E | President and CEO | Buy | M | 1.75 | 109,563 | 191,735 | 165,263 | 55.7 K to 165.3 K (+196.70 %) |
Feb 23 2007 | NTII | NEUROBIOLOGICAL TE ... | FREIMAN PAUL E | President and CEO | Sell | S | 2.73 | 10,437 | 28,474 | 55,700 | 66.1 K to 55.7 K (-15.78 %) |
Feb 23 2007 | NTII | NEUROBIOLOGICAL TE ... | FREIMAN PAUL E | President and CEO | Buy | M | 1.75 | 10,437 | 18,265 | 66,137 | 55.7 K to 66.1 K (+18.74 %) |
Feb 23 2007 | NTII | NEUROBIOLOGICAL TE ... | FREIMAN PAUL E | President and CEO | Sell | S | 2.73 | 25,000 | 68,205 | 55,700 | 80.7 K to 55.7 K (-30.98 %) |
Feb 23 2007 | NTII | NEUROBIOLOGICAL TE ... | FREIMAN PAUL E | President and CEO | Buy | M | 2.00 | 25,000 | 50,000 | 80,700 | 55.7 K to 80.7 K (+44.88 %) |
Feb 22 2007 | NTII | NEUROBIOLOGICAL TE ... | Fletcher William A | Director | Option Exercise | A | 2.75 | 50,000 | 137,500 | 50,000 | |
Feb 15 2007 | NTII | NEUROBIOLOGICAL TE ... | ELIOT THEODORE | Director | Option Exercise | M | 2.00 | 25,000 | 50,000 | 0 | |
Feb 15 2007 | NTII | NEUROBIOLOGICAL TE ... | ELIOT THEODORE | Director | Sell | S | 2.65 | 19,300 | 51,145 | 18,322 | 37.6 K to 18.3 K (-51.30 %) |